Clinical trial
Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation…
NCT00431834 · Medtronic Cardiovascular, Industry · Completed
Key facts
| NCT number | NCT00431834 |
|---|---|
| Title | Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study |
| Official title | Medtronic Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF)/Permanent Study |
| Lead sponsor | Medtronic Cardiovascular, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Device, Procedure |
| Interventions | Cardioblate System Surgical Ablation System, Surgical RF Ablation |
| Enrollment | 75 |
| Start date | May 1, 2007 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | Feb 6, 2007 |
| Last update posted | Nov 27, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: